| |
|
|
|
RedHill Biopharma Ltd.  
|
|
6.81 -0.08 (-0.01%) |
06-21 16:00 |
|
Open: |
6.98 |
Pre close: |
6.89 |
Target:
|
8.70 
|
|
High: |
6.98 |
Low: |
6.8 |
Resistance:
|
7.45
7.85
|
|
Volume: |
29,259 |
Market Cap: |
193M |
Support:
|
6.80
5.66
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.02
|
MACD |
MACD(12,26):
|
-0.20 |
|
MA(20): |
7.26 |
Signal(12,26,9): |
-0.18 |
|
MA(100): |
8.01 |
Stochastic Oscillator |
%K(14,3):
|
7.00 |
|
MA(250): |
7.89 |
%D(3): |
16.85 |
|
Average Volume(K) |
3-Month: |
5251
|
52-Week |
High:
|
11.49 |
|
10-Days: |
8659 |
Low: |
5.13 |
|
RSI |
RSI(14):
|
33.56 |
Change(%): |
-13.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.580 |
Return on Equity (ttm) |
-99.2 |
Shares Out. (M) |
234.96 |
|
EPS Est. Current Year |
-2.390 |
Return on Assets (ttm) |
-46.1 |
Shares Float (M) |
13.57 |
|
EPS Est. Next Year |
-0.540 |
PEG Ratio |
0.00 |
% Held by Insiders |
19.10 |
|
EPS Est. Next Quarter |
-0.620 |
Qtrly Rev. Growth |
-29.0 |
% Held by Institutions |
29.11 |
|
Forward EPS |
-0.320 |
Gross Profit (p.s.) |
0.023 |
Shares Short (K) |
316 |
|
Book Value (p.s.) |
1.480 |
EBITDA (p.s.) |
-0.163 |
P/E |
-4.31 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.60 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-32.50 |
P/S |
5161540608.00 |
|
Operating Margin |
-503.78 |
Levered Free Cash Flow
(M) |
-19.93 |
P/CF |
-49.23 |
|
|
|
|
|
|
